Pediatric parenteral nutrition, oil-in-water emulsion, multi-chamber containers
Summary
USPTO published patent application US20260090983A1 for pediatric parenteral nutrition formulations comprising lipid emulsions in oil-in-water form. The application also covers multi-chamber containers for separating carbohydrate, amino acid, and lipid formulations until administration. Inventors include Jean-Luc Trouilly, Mary Hise Brown, Laurent Jeannin, Julien Hecq, and Julie Fahier.
What changed
USPTO published a patent application (US20260090983A1) for pediatric parenteral nutrition formulations comprising a lipid formulation with aqueous and oil phases in an oil-in-water emulsion configuration. The application also discloses multi-chamber containers with separate compartments for carbohydrate, amino acid, and lipid formulations. CPC classifications span A61K (preparations for medical purposes), A23 (foods), and A61J (containers for medical preparations). Application No. 19318846 was filed September 4, 2025.
Patent applications do not create immediate regulatory obligations. Healthcare providers, pharmaceutical companies, and medical device manufacturers monitoring this technology space should note the formulation approach for pediatric nutrition delivery. No compliance deadlines or penalties apply to this publication.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PARENTERAL NUTRITION FORMULATION
Application US20260090983A1 Kind: A1 Apr 02, 2026
Inventors
Jean-Luc TROUILLY, Mary HISE BROWN, Laurent JEANNIN, Julien HECQ, Julie FAHIER
Abstract
Parenteral nutrition formulations for pediatric patients are disclosed. The nutritional formulations include a lipid for mulation that comprises an aqueous phase and an oil phase, wherein the lipid formulation is in the form of an oil-in-water emulsion. Multi-chamber containers for parenteral nutrition administration comprising a carbohydrate formulation present in a first chamber, an amino acid formulation present in a second chamber, and the lipid formulation present in a third chamber also are disclosed.
CPC Classifications
A61K 9/0029 A23B 20/10 A23D 7/0053 A23D 7/011 A23L 33/11 A23L 33/12 A23L 33/125 A23L 33/175 A23L 33/40 A61J 1/10 A61J 1/2093 A61J 3/002 A61K 9/107 A61K 31/14 A61K 31/202 A61K 31/232 A61K 31/661 A61K 31/685 A61K 36/05 A61K 47/10 A23V 2002/00
Filing Date
2025-09-04
Application No.
19318846
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.